Unique technology, amazing people
iota Biosciences is made up of a proudly diverse team of exceptional people. We come from different backgrounds and bring different skills, but we all share a passionate belief in the power of innovative bioelectronics to improve health and transform lives. As a team we work collaboratively and cross-functionally, with a strong connection to doctors and patients, to ensure that what we are developing is aligned with their core needs. We continually challenge what’s possible and inspire each other to think differently as we create and design cutting-edge technologies with the potential to change lives.

Speed without compromise
We know that some patients don’t have time to wait. Driven by passion and tenacity, we combine a rigorous focus on quality with the agility and adaptability to keep moving our ideas and innovations forward, fast.
“We have a culture of moving fast and embracing change. iota allows everyone to maintain their individuality while adhering to quality practices.”
Meet our leadership team

Michel Maharbiz, PhD
Chief Executive Officer (CEO)
Michel cofounded iota Biosciences in 2017. He is a serial entrepreneur and in his spare time loves bouldering, hiking and off-roading.

Gil Mandelbaum, PhD
General Manager, Neurological Therapies
Senior Director, Neuromodulation and BCIs

Michael Woods, MD
General Manager, Urological Therapies
Senior Director, Bioelectronic Medicine

Rebecca Crane
Senior Director of Quality and Business Operations

Lusin Markaryan
Senior Director of Regulatory Affairs

Cameron Esacoff
Senior Director Engineering and Manufacturing

Michelle Patruno
Director of Human Resources

Jami Maccombs
Director of Clinical Operations

Michel Maharbiz, PhD
Chief Executive Officer (CEO)
Michel cofounded iota Biosciences in 2017. He is a serial entrepreneur and in his spare time loves bouldering, hiking and off-roading.
Until 2021, Michel was a Full Professor and is now an Adjunct Professor, with the Department of Electrical Engineering and Computer Science at the University of California, Berkeley. Prof. Maharbiz received his B.S. from Cornell University and his Ph.D. from the University of California, Berkeley under nanotechnologist Professor Roger T. Howe (EECS) and synthetic biologist Professor Jay D. Keasling (ChemE). He is a Senior Member of the IEEE (Engineering in Medicine and Biology Society) and a member of the Society for Neuroscience. Prof. Maharbiz is a recipient of the McKnight Foundation’s Technological Innovations in Neuroscience Award (2017), a Chan-Zuckerberg (CZ) Biohub Investigator (2017), a Bakar Fellow (2014) and recipient of a National Science Foundation CAREER Award (2009).

Gil Mandelbaum, PhD
General Manager, Neurological Therapies
Senior Director, Neuromodulation and BCIs
Gil Mandelbaum is the Senior Director of Neuromodulation and Brain-Computer Interfaces (BCIs), as well as the General Manager of Neurological Therapies at iota Biosciences. He leads teams dedicated to developing, deploying, and commercializing technologies that modulate the brain’s electrical or chemical activity (neuromodulation), interpret brain signals to control external devices (BCIs), or integrate both approaches. His work spans research, product development, clinical trials, and commercialization—driving innovations that improve outcomes in neurological conditions and enable new forms of human–machine interaction.
A neuroscientist by training, Gil holds a dual undergraduate degree in Chemistry and Biology from Tel Aviv University and earned his PhD and completed postdoctoral training at Harvard Medical School. With over 15 years of neuroscience research experience, he has developed a wide range of experimental approaches, including pioneering hardware, software, and research systems. His contributions have helped establish a neuroscience research tools company and have been published in leading journals such as Nature Neuroscience. His work has also been featured in Nature Methods and appeared on the cover of Neuron.
Gil is passionate about helping the iota team deliver solutions that directly address long-standing challenges faced by stroke survivors with upper limb impairments - transforming bold scientific ideas into impactful clinical solutions while unlocking scalable neurotechnology applications.

Michael Woods, MD
General Manager, Urological Therapies
Senior Director, Bioelectronic Medicine
Mike is the Senior Director of Bioelectronic Medicine and the General Manager of urological therapies at iota Biosciences, initially focused on patients with underactive bladder. Collaboratively leading engineering, manufacturing, clinical operations, project management, regulatory affairs, quality, and pre-market activities, and using his surgical expertise, he is responsible for all aspects of the device program.
Mike is a fellowship-trained, board-certified surgeon who obtained his BSc in cellular biology and MD and surgery degrees from the University of Kansas and an MBA in medical management from the University of Southern California. His career spans clinical surgery, leadership roles in surgery, health systems, healthcare start-ups, medical software and data science, and global pharmaceutical development.
He is excited about helping the iota team bring the Akyva device to market to help millions of patients with underactive bladder lead more normal lives.

Rebecca Crane
Senior Director of Quality and Business Operations
Rebecca takes the lead in ensuring iota Biosciences meets safety, efficacy, and regulatory standards. She also oversees key business operations and strategic initiatives to improve operational performance. Outside of work, she enjoys spending time off-roading and other outdoor activities.
Rebecca possesses extensive experience in quality management and continuous improvement initiatives within the medical device industry, integrating her engineering background into product development and the quality management system processes. Her prior experience includes roles at Medtronic, SetPoint Medical, and Advanced Bionics. Her proficiency spans new product development, risk management, quality management systems and technically focused, data-driven continuous improvement initiatives. She has a BS in Engineering and Applied Science with a focus in Computation and Neural Systems from Caltech.
“I joined iota for its collaborative culture, technical excellence, and shared drive to innovate and build impactful products together.”

Lusin Markaryan
Senior Director of Regulatory Affairs
As Head of Regulatory Affairs, Lusin leads a team responsible for obtaining and maintaining approval for iota’s medical products. Outside of work her passion is travel and she has so far visited 21 countries.
Lusin has more than 20 years of experience in regulatory affairs for medical devices. She was formerly a Vice President of Regulatory Affairs at SetPoint Medical where she received approval for FIH and pivotal clinical trials of a bioelectronic medicine device. Prior to SetPoint, she was a Director of Regulatory Affairs at Medtronic Diabetes where she authored an original PMA.
Lusin received her undergraduate degree from University of California, Irvine, and has earned the Regulatory Affairs Certificate (RAC) for both U.S. and the European Union.
“iota has innovative technology, an incredible leadership team and an effective and energetic team of experts working together to achieve the company goals.”

Cameron Esacoff
Senior Director Engineering and Manufacturing
Cameron is a passionate results-driven leader, innovator, and collaborator with nearly a decade of experience in the Class III Implantable Medical Device Industry. Outside of his professional life, he enjoys designing and building dynamic multi-disciplined art projects and sculptures and spending quality time with his family.
With a broad perspective, Cameron’s prior accomplishments have demonstrated a high degree of ownership and collaboration through multiple product phases: from early development, through manufacturing, to FDA submissions & approvals, and ultimately to field deployment. His formal training is in Mechanical and Electrical Engineering.
“I joined iota Biosciences to deliver novel diagnostics and therapies to underserved patient populations. Iota is a vast landscape of many diverse and rewarding opportunities, with a highly competent team that work with camaraderie, pride, and integrity.”

Michelle Patruno
Director of Human Resources
Michelle is responsible for leading People strategy at iota Bio, with a focus on cultivating a thriving workplace culture that fosters talent and growth.
Michelle is a passionate People Leader with over 15 years of People experience. She has expertise in scaling early technology organizations and a track record of fostering strong workplace cultures and optimizing HR operations. She values trust and empathy to create stainable solutions to complex people problems. Michelle holds a Bachelor of Arts in Global Economics from the University of California, Santa Cruz.
She enjoys camping, hiking with her pup and traveling in her free time.
“I’m inspired by working for an organization with a central mission to develop technology that could dramatically improve patients’ lives and attracting employees that deeply connect to the work we’re doing.”

Jami Maccombs
Director of Clinical Operations
Jami is a seasoned clinical affairs professional with extensive experience in the medical device industry, advancing clinical research at iota since 2024.
As a clinical affairs leader, Jami has a comprehensive background in cardiology, having led numerous cardiovascular PMA trials and held key roles at Edwards Lifesciences, Abbott and Medtronic. She worked on several landmark studies for the Ardian, MitraClip, TriClip, Portico, Amulet and HARPOON devices. Jami's career began at The Ohio State University Medical Center, where she focused on heart failure, pulmonary hypertension, and sleep apnea research. Currently pursuing an MBA from the University of Illinois, Jami combines clinical expertise with strategic leadership.
“I joined iota Biosciences to help pioneer technologies that transform patient care.”